CAS RN: 1481401-71-1

2,1,3-Benzoxadiazol-4-amine, N-[2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]ethyl]-N-methyl-7-nitro-

Product Availability

Choose a grade to view its available package options.

6 package records4 with current stock2 grade groups
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20251002 10mg In stock Inquiry
Batchno.20250711 1mg Out of stock Inquiry
Batchno.20250502 25mg In stock Inquiry
Batchno.20250528 50mg In stock Inquiry
Batchno.20250410 5mg In stock Inquiry
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20251228 1mg / 5mg / 10mg Out of stock 5-7 business days Inquiry
  • Product code: starshine_CAS1481401-71-1
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1481401-71-1 / N-[2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]ethyl]-N-methyl-4-nitro-2,1,3-benzoxadiazol-7-amine

Standard CAS: 1481401-71-1 Multi CAS: No

Basic Information

CAS
1481401-71-1
Multi CAS
No
Molecular Formula
C31H28N4O4
Molecular Weight
520.600000
Exact Mass
520.211055
SMILES
CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C3=CC=C(C4=NON=C34)[N+](=O)[O-])/C5=CC=CC=C5
InChI
InChI=1S/C31H28N4O4/c1-3-26(22-10-6-4-7-11-22)29(23-12-8-5-9-13-23)24-14-16-25(17-15-24)38-21-20-34(2)27-18-19-28(35(36)37)31-30(27)32-39-33-31/h4-19H,3,20-21H2,1-2H3/b29-26-
InChIKey
UKSXWLGSDIHAEK-WCTVFOPTSA-N

Computed Properties

Structural Parameters

Heavy atom count
39
Aromatic heavy atom count
27
Fraction Csp3
0.16
Rotatable bonds
10
H-bond acceptors
7
Molar refractivity
152.76
TPSA
94.53

LogP / Solubility

WLOGP
7.02
MLOGP
6.21
XLogP3
8
Consensus LogP
7.08
Log S (ESOL)
-7.34
Class (ESOL)
Insoluble
Log S (Ali)
-8.89
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-10.07
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-0.91

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
Yes
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
5

Get In Touch

Contact Us